Compare LONA & JFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LONA | JFU |
|---|---|---|
| Founded | 2011 | 2006 |
| Country | United States | China |
| Employees | 26 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.4M | 54.5M |
| IPO Year | N/A | 2018 |
| Metric | LONA | JFU |
|---|---|---|
| Price | $9.07 | $3.18 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 73.1K | 2.4K |
| Earning Date | 03-26-2026 | 12-09-2022 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $1.43 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.21 | $1.01 |
| 52 Week High | $14.21 | $9.48 |
| Indicator | LONA | JFU |
|---|---|---|
| Relative Strength Index (RSI) | 58.35 | 36.70 |
| Support Level | $4.52 | $2.43 |
| Resistance Level | $14.21 | $4.91 |
| Average True Range (ATR) | 1.74 | 0.21 |
| MACD | 0.02 | -0.08 |
| Stochastic Oscillator | 36.01 | 16.18 |
LeonaBio Inc is a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS).
9F Inc is a financial account platform integrating and personalizing financial services in China. It provides a range of financial products and services across online lending, wealth management, and payment facilitation, all integrated under a single digital financial account. The company's operations are organized into Material segments, consisting of E-commerce services, technology Empowerment service and Wealth Management services, of which it derives maximum revenue from technology Empowerment service. All its revenues are generated from the People's Republic of China.